Content uploaded by Eduardo Mendonça Pimenta
Author content
All content in this area was uploaded by Eduardo Mendonça Pimenta on Sep 09, 2015
Content may be subject to copyright.
This provisional PDF corresponds to the article as it appeared upon acceptance.
A copyedited and fully formatted version will be made available soon.
The final version may contain major or minor changes.
Subscription: Information about subscribing to Minerva Medica journals is online at:
http://www.minervamedica.it/en/how-to-order-journals.php
Reprints and permissions: For information about reprints and permissions send an email to:
journals.dept@minervamedica.it - journals2.dept@minervamedica.it - journals6.dept@minervamedica.it
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
The alpha-actinin-3 R577X polymorphism and physical
performance in soccer players
THE JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS
THEALPHAACTININ3R577XPOLYMORPHISMANDPHYSICALPERFORMANCEIN
SOCCERPLAYERS
D. Coelho1, E. Pimenta2, I. Rosse3, C. Veneroso3, L. Becker1, M. R. Carvalho4, G.pussieldi5, E.
SilamiGarcia3
1DesportiveCenterofFederalUniversityofOuroPreto,OuroPreto,Brazil
2DepartmentofBiomedicalSciences,UniversityofLeon,Leon,Spain.
3Sports Department, School of Physical Education, Physiotherapy and Occupational Therapy, Federal
UniversityofMinasGerais,BeloHorizonte,Brazil.
4Department of General Biology, Laboratory of Human and Medical Genetics,– Institute of Biological
Sciences–FederalUniversityofMinasGerais,BeloHorizonteBrazil.
5Physical Education Department, Federal University of Viçosa – Campus Florestal, Florestal, Minas
Gerais,Brazil.
Congresses: Presented at the 61th Annual Meeting and4th World Congress on Exercise is Medicineof
theAmericanCollegeofSportsMedicine,May28June1,2014.
Funding: National Committee for Scientific and Technological Development (Conselho Nacional de
Desenvolvimento Científico e Tecnológico [CNPq]), Coordination and Improvement of Superior
Education Staff (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior [CAPES]), Foundation
for Support to Research in the State of Minas Gerais (Fundação de Amparo à Pesquisa do Estado de
1
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
Minas Gerais (FAPEMIG) and ProRectory of Research of the Federal University of Minas Gerais
(PróReitoriadePesquisadaUniversidadeFederaldeMinasGerais(PRPQUFMG)),
Conflictsofinterest:Theauthorshavenoconflictofinteresttodeclarewithregardtothepresentwork.
Acknowledgements: To the laboratory São Sebastião (Cel Fabriciano, MG) and laboratory management
EliasJosédeSalesFilhoandlaboratorytechincalMarcileneHonoratoPiresbythClinicalanalyses.
Corresponding Author: D. Coelho, Frei Orlando avenue, 1035\302, Caicara, Belo Horizonte, Minas
Geraisstate,Brazil.Email:danielcoelhoc@gmail.com.
2
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
Abstract
The aim of this study was to investigate the association between ACTN3 genotype (RR, RX, and XX) and
physical performance of 138 adult, professional, U20 and U17 years Brazilian firstdivision soccer players.
The following three parameters were investigated: first, speed, using a 30m sprint test with speed measured at
10 m, 20 m, and 30 m second, muscular strength, using countermovementjump and squat jump tests and
third, aerobic endurance using the YoYo endurance test. The athletes were ranked in ascending order
according to their performance in each test. after which they were divided into quartiles and clustered according
to genotype and allele frequency. The X2was used to compare the genotype frequencies (RR, RX and RR) and
allele frequencies (R and X) within and between the different quartiles of performance rating. No significant
differences were observed in genotypic or allelic frequencies between different performance ratings. The
ACTN3 genotype was not associated to any of the physical performance parameters. This information should
be noted with care, because, besides physical capacity, there are other factors, like tactical knowledge, that
interferewithperformanceinsport,consideringthatexpertiseismultifactorial.
Keywords:SoccerACTN3PerformanceStrengthAerobiccapacity
3
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
Introduction
Soccer has a worldwide audience and can be played by people of both genders and all ages around the
world.1During a soccer match, a player covers a distance of 8–12 km by movements that range from walking
to running at maximum speed.2The aerobic energy pathway predominates during the long game, but exertions
that lead to the final movements, such as sprints, jumps, heading, dribbling, and shots on goals, have
anaerobic.3Due to these characteristics, soccer may be classified as an intermittent and high energy activity.4
Therefore, soccer players should be aerobically well trained and possess significant strength and speed in order
toperformathighlevels.5
The maximal oxygen uptake and strength are important physical capacities in soccer player. The Yoyo
test, is a standard test to evaluated the aerobic performance on soccer6,7 and anaerobic performance is measure
byspeedandjumpingtests.8
Field tests are closer to the athlete's reality, as they are carried out movements similar to those
implemented in the game. In addition, this type of test is more motivational in comparison with laboratory
situation.9
In recent times, there has been a suggestion of a possible natural selection for highperformance sports
according to the predominance of aerobic or anaerobic capacity, strength, or resistance10, or as in the case of
soccer, all of these.11,12,13A successful sports career has been associated with the expression of certain genes that
caninfluencephysicalability.14,15,16,17,18However,somestudiesdidnotobservethisassociation.19,20
Among the several genes related to sports performance21, the gene encoding the alfaactinin3 ACTN3
is one of the most frequently studied genes in this context.22,23 This sarcomeric protein is specific to type II
muscle fibres and plays an important structural role in the arrangement and transfer of traction between actin
filamentsandtheZline.24
5
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
ACTN3 has two alleles: R, which encodes a functional copy of the protein, and X, which encodes a
nonfunctional version of the protein.
The
ACTN3 RR and RX genotypes have been associated with high speed
and strength in athletes25,26,28,29 including soccer players30, and the XX genotype has been associated with
aerobicendurance.10,14,16,31,32,33
Date shown that the genetic profile is related with sport performance and this influence increases at
higher competitive levels. Yang et al. (2003) identified a higher frequency of ACTN3RR genotype and allele
R in professional athletes enrolled in modalities that require strength and power physical capacities, in the other
hand,ACTN3XXandXalleleismorefrequentlyinathleteswithhighenduranceperformance.
Considering the above, the aim of this study was to investigate the association between performance
(viaphysicaltests)andtheACTN3genotype(RR,RX,andXX)inBraziliansoccerplayers.
Methods
Ethicalcares
This study was approved by the Research Ethics Committee of the Federal University of Minas Gerais
(ETIC291/09) and complied with all the norms established by the National Health Council (Res. 196/96)
regarding research with human beings. All procedures, possible risks and benefits of the study were explained
tothevolunteersbeforetheysignedtheinformedwrittenconsenttoparticipateintheexperiment.
Subjects
138 male athletes of categories of Under17, Under20 and professionals of a Brazilian first division
Soccer team that kept regular training sessions and compete in official events acknowledged by the Brazilian
6
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
Soccer Federation (CBF) took part in this study (Table 1). The athletes had an average of 4.5 ± 2.5 years of
experience. Apart from the competition periods, the players had at least 2 years of experience in competitive
footballandtrainedforanaverageofnine2hsessionsover6dayseachweek.
Procedures
Testing was performed outdoors and on artificial turf. A standardized warm up of 10 – 15 min was
performed that included jogging, shuffling, sprinting, multidirectional movements and dynamic stretching
exercises.
Day1
The players underwent a 30m sprint test on a grass track, and their speeds were determined for the
initial 10 m (V10) the remaining 20 m, with the athletes already in motion (V20) and over the entire 30 m
(V30). Measurements were taken electronically using three photoelectric barriers (positioned at waist height
approximately 1 m off the ground), with an accuracy of 0.001 s, located at 0 m, 10 m, and 30 m along the track.
Each subject had three attempts separated by approximately three minutes to ensure full recovery. Subjects
commenced each sprint from a standing (static) position in which their front foot was placed 50 cm behind the
start line. Subjects decided themselves when to start each run with the time being recorded when the subject
intercepted the photocell beam. All the volunteers were instructed to sprint as fast as possible through the
distance. All three barriers were connected to a computer, and the software MultiSprint®was used to analyse
speed.
Day2
At least 48h after the previous test, two performance tests were included to evaluate the explosive
power of the leg extensor muscles on a force platform connected with a digital timer (0.001 s.) (Jump Test®
Brazil). This system determines flight time, which is converted to jump height using the following equation: h
7
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
= (g (t ²))/8 (where g = acceleration due to gravity and t = air time).34 The tests used were Squat Jump (SJ) and
CounterMovement Jump (CMJ). Subjects performed the CMJ and SJ with their hands kept on their hips
throughout the jumps. During the SJ, with knees at 90° of flexion, the subjects were instructed to execute a
maximal vertical jump and were not allowed to use any downward movement prior to the maximal vertical
jump. The force curves were inspected to verify no downward movements prior to the vertical jump. During the
CMJ, the angular displacement of the knees was standardized so that the subjects were required to bend their
knees to approximately 90º and then rebound upward in a maximal vertical jump. Each subject had four
attemptsinterspersedwithapproximatelya1.5minuterestbetweeneachjumpinboththeSJandCMJ.
The best jump from each subject was used in the data analysis. Performance using a timing mat can be
influenced by body position during flight therefore the participants were instructed and carefully observed to
maintain straight legs while airborne. If the knees were bent or raised, the trial was discarded and the
participant was given another attempt following a rest period. Since jumping without arm action is not common
insport,techniquewasdemonstratedtoeachparticipant,followedbytwosubmaximalattempts.
Day3
Two days after the tests to ascertain vertical jump and sprint test, the players undertook a VO2max test
after a thorough warm up. The VO2max was measured using the YoYo endurance field test.6This test was
specifically designed for soccer and intermittent sports7, in which the distance run intermittently is directly
related to the aerobic capacity of the athletes.6Even though field tests are not considered gold standard to
determine physiological variables, it has been suggested that relevant, specific and operative field tests should
beusedinteamsports.7,35
All of the physical tests were carried out by a professional expert in this subject (a soccer physiologist)
along with a researcher, and in accordance with club regulations. These tests were carried out at the start of the
training season before the athletes had begun a period of physical preparation. All of the athletes were familiar
with these tests because they form part of the club assessment process. The tests were carried out three times in
8
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
succession, with a full recovery between each attempt the best results for each athlete were used for the
analysis. The YoYo test was performed only twice because of the reasons of fatigue. The minimum time
intervalbetweentestswas48hours.
All athletes were housed at the training center of the club and arrived the same day. All of them were in
vocation for 30 days. The players followed the same schedule of training and hours of sleep. All meals were
takenatthesametimesandwithadietsupervisedbytheclub'snutritiondepartment.
The players participating in the study were older than 16 years old (to minimise the interference of
factors such as maturation or experience in physical tests) and were categorized as under17, under20, and
professionals. The athletes were ranked by performance in each test, and then the groups were subdivided into
quartiles, in crescent order of performance, thereby obtaining the first quartile (0–25%, weak), second quartile
(25–50%, normal), third quartile (50–75%, good), and fourth quartile (75–100%, excellent) of the results
(Table 2). Then, in each quartile, the players were categorized by genotype (RR, RX, and XX), and the
genotypicfrequencieswerecomparedbetweenthegroups.
GenotypingoftheR577XpolymorphismintheACTN3
gene
We collected blood samples for genotyping of the athletes by using the vacuum method, in 2 4mL
EDTA tubes (Vacuette®). This sample was collected through venous puncture performed by one of the
investigatorsoratrainednurse.Thetubeswerestoredat4°CuntilDNAextraction.
The extraction of genomic DNA from the peripheral blood samples was performed according to
literature protocol, using proteinase K followed by salt precipitation.36 A DNA fragment carrying the exon 16
from the ACTN3 gene was amplified from the genomic DNA and the following initiators were used: Forward:
5’CTGTTGCCTGTGGTAAGTGGG3’ reverse: 5’TGGTCACAGTATGCAGGAGGG3’, correlated to the
adjacent intronic sequences. The PCR reactions presented a final volume of 25 µL, with 10 mM Tris, pH 8.4,
9
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
50 mM KCl, 1.75 mM MgCl2, 0.1% Triton X100, 0.2 mM of each dNTP (Invitrogen, Carlsbad, CA), 1 U Taq
DNA polymerase (Phoneutria Biotecnologia, Belo Horizonte, MG, Brazil) and 1.0 M of each initiator
(SINAPSE BIOTECNOLOGIA, São Paulo, SP, Brazil), using about 100 ng of genomic DNA as mold. The
amplification program consisted of an initial denaturation at 94°C for 5 min, followed by 30 cycles, comprising
94°C for 1 min, 64°C for 1 min and 72°C for 1 min, with a final extension of 72°C for 5 min. The R577X
alleles (codons CGA and TGA) were distinguished by the presence (577X) or absence (577R) of a restriction
site of the enzyme DdeI.37 After amplification by PCR, 1 µL of the product of PCR was digested with 20 U of
the enzyme DdeI in a final volume of 15 µL. The reactions were incubated overnight (O/N) at 37°C. Later, the
fragments digested were separated by electrophoresis with polyacrylamide gel 8%, stained with silver nitrate
solution.38 The ACTN3 577R allele generates fragments in 205 and 86 base pairs (bp), while the ACTN3 577X
allelegeneratesfragmentsin108,97and8618(Fig.1).
Given the phenotypical similarity of ACTN3 RR and RX, individuals with these genotypes were
groupedtogetherandcomparedtogroupXX.
Figure1"Here".
Statisticalanalysis
The data were analysed using descriptive and inferential statistics. For this statistical analysis, the
software Statistical Package for the Social Sciences for Windows, version 14.0, was used. The qualitative
variables were presented as absolute and relative frequencies. The X2was used to compare the genotype
frequencies (RR, RX and RR) and allele frequencies (R and X) within and between the different quartiles of
performance rating. The level of significance was 5% that is, a value was considered significant when p ≤
0.05.
10
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
Results
DataforthecharacteristicsofthesubjectsusedareshowninTable1.
Table1"Here".
The results of physical tests used for the classification of athletes in different quartiles are presented in
Table 2. The consistency values (ICC, 1.1) and the standard error of the mean (SEM)39 for the results of the
physical tests were V10, 0.98 and 2.5% V20, 0.96 and 2.9% V30, 0.96 and 2.8% SJ, 0.94 and 3.5% CMJ,
0.95and3.1%andYYo,0.92and3.6%,respectively.
Table2"Here".
As shown in Tables 3 and 4, no significant differences were observed in genotypic or allelic frequency
betweenthedifferentperformancequartiles.
Table3"Here".
Table4"Here".
Discussion
Given the speed and strength requirements of soccer, in this study, we expected to find the highest
frequencies for the RR and RX genotypes and the R allele in the groups showing high performance in the speed
and strength tests. We also expected to find the highest frequencies for the XX genotype and the X allele in the
groups with high performance in the aerobic capacity test. However, no significant differences were found in
genotypicorallelicfrequencybetweenthedifferentperformancequartilesforthesoccerplayers.
11
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
The failure to identify any association between genotypic frequency and performance is supported by
the fact that other studies also found no association between the genotypic or allelic frequency of ACTN3 and
athlete competitive level, using the 30m speed test and the jump tests (SJ and CMJ)27, as well as longdistance
endurance tests such as Ironman events.24 Other studies on healthy individuals did not find any differences in
theACTN3genotypewithregardtospeedorintensity27,ormaximalaerobiccapacity(V02Max).33
The data from this study contradict the findings of Yang et al. (2003), which linked the genotypic and
allelic frequency of ACTN3 with athlete competitive levels in various high endurance and strength tests.
Moreover, the authors cited identified an increase in frequency of the RR genotype and the R allele in athletes
specialising in high strength or intensity activities at high competitive levels as well as an increase in the
frequencyofXXandtheXalleleinathletesspecialisinginendurance.
Other studies found an association between the genotypic frequency of ACTN3 and performance in
activities including running40 and rowing10, as well as in healthy individuals.26 However, in team sports such as
soccer, it is not only the physical condition that affects high performance but also tactics and the technique of
eachindividual.
Note that the tests undertaken in this study are more specialised field tests, which are widely applicable
and convenient in sport.7,9,35 However, field assessment measurements vary more than standardised laboratory
tests.
One must also consider that, in this study, actions involving multiarticular coordination, such as
runningandjumping,canaffectperformance9,unliketheuniarticularactionscommonlyusedinthelaboratory.
In isokinetic laboratory tests, men26 and women28 with the RR genotype showed better performance at
higher angular speeds. However, this was not observed by Hanson et al. (2010), who only found better
performanceintheisokineticorWingatetestsinhealthyadolescents.
Other studies that did not find any association between performance and the genotypic frequency of
ACTN3 have put this down to a small N value or the low competitive levels of the athletes studied.19,33 In this
12
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
study, even though the competitive level is high and the number of volunteers is representative with regard to
the number of professional players in action, differences that were not identified may still exist, which could be
consideredalimitationofthisstudy.
Garganta et al. (2002) state that soccer is a sport of varying speeds. Because each player on the soccer
pitch differs in role and game tactics, physical characteristics may have a lesser effect on performance than in
individual sports. It may be that the genetic influence is more likely to be seen in strength and endurance sports
orinactivitiesincontrolledenvironmentslikealaboratory.
Given that the ACTN3 gene has been reported to affect muscle strength at high intensities, it was
expected that a greater number of individuals with the RR and RX genotypes would be found in higher
performance quartiles for the CMJ, V20, and V30 tests, as there is greater muscular contraction in the
stretchshortening cycle for these tests than in the SJ and V10 tests41 and it would be expected that this cycle
would be influenced by the presence of the alphaactinin3 genotypes RR and RX. It has been suggested that
plyometric training causes greater hypertrophy in type II fibres, refined compliance of elastic components in
series, and a decrease in contraction time, thereby increasing the stretchshortening cycle. Although this has
only been seen in an animal model42 and not in humans43, nonetheless, this could be considered a possible
adaptationtoplyometrictraining,whichisinherentinsoccer.
Alphaactinin3 withstands traction within the actin filaments attached to the Zline at high magnitudes
of muscle contraction, specifically in type II fibres. Therefore, it would be expected that RR/RX individuals,
who express alphaactin, would show greater adaptation to plyometric training and perform better in activities
requiring this type of muscular contraction than XX individuals. However, this could not be confirmed in this
study.
Identifying the genetic profile of an aptitude for certain physical characteristics could be important for
the coaching staff of a team, as then the less able athletes could be left out of intense training. It is still possible
that XX athletes are less able with regard to the physical characteristics that modern soccer requires, including
13
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
high speed and strength these athletes may require greater resting periods after matches and training sessions.
It has been shown in humans that ACTN3 XX individuals were more prone to muscle microtrauma after
eccentric exercise,18, 28 although this was not confirmed in another study44 or in an animal model.31 This feature
could affect sport performance, because it would determine adaptability to training21,44 or the distribution ratio
oftypesofmotorunits.28
One must bear in mind that success in sport, particularly, in multiskilled activities like soccer, cannot
solely be attributed to a single gene. Moreover, given the vast array of genes related to sport,22,23 the greater the
number of these genes in the individual, the greater the possibility that their effects will be noticeable. It is
likely that ACTN3 is a selection factor for athletes, conferring an advantage in some sports however, this is
still not certain, because genotype is only responsible for part of the athlete’s success, and environmental
factorscannotbedisregarded.25
Conclusion
In this study, no association was found between ACTN3 genotypic or allelic expression and
performance in soccer players during physical tests of strength, speed, and endurance. However, this
information must be observed with caution, because there are other factors besides physical capacity that
influencesportingperformance.
References
1. FIFA FEDERATION INTERNATIONALE DE FOOTBALL ASSOCIATION. www.fifa.com. Accessed in
January2014.
14
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
2. Barros R, Misuta M, Menezes R, Figueroa P, Moura F, Cunha S, et al. Analysis of the distances covered by
first division Brazilian Soccer players obtained with an automatic tracking method. J Sports Sci Med.
20076(2):233242.
3. Stolen T, Chamari K, Castagna C, Wisloff U. Physiology of soccer: An update. Spor Med.
200535(6):501536.
4.HoffJ.Trainingandtestingphysicalcapacitiesforelitesoccerplayers.JSportsSci.
200523(6):573–582.
5.MohrM,KrustrupP,BangsboJ.FatigueinSoccer:abriefreview.JSportSci.
200523(6):593599.
6. Bangsbo J, Iaia M, Krustrup P. The YoYo intermittent recovery test. A useful tool for evaluation of physical
performanceinintermittentsport.SportsMed
.200838(1):3751.
7. Krustrup P, Mohr M, Ellingsgaard H, Bangsbo J. Physical demands during an elite female soccer game:
importanceoftrainingstatus.MedScienSporExer
.200537(7):12421248.
8. Pimenta E,Coelho D, Coelho E, Cruz I, Morandi R, Pussieldi G, et al. Effect of ACTN3 gene on strength
and endurance in soccer players. J Strength Cond Res
. 2013 27:3286–3292. doi:
10.1519/JSC.0b013e3182915e66
9. RodriguezRomo G, Ruiz J, Santiago C, FiuzaLuces C, GonzalezFreire M, GomezGallego F, et al. Does
the ACE I/D polymorphism, alone or in combination with the ACTN3 R577X polymorphism, influence muscle
powerphenotypesinyoung,nonathleticadults?EurJApplPhysiol
.2010110(6):10991106.
10. Ahmetov II, Popov DV, Astratenkova IV, Druzhevskaya AM, Missina SS, Vinogradova OL, et al. The Use
of Molecular Genetic Methods for Prognosis of Aerobic and Anaerobic Performance in Athletes. Hum Physiol
.
200834(3):338–34.
11. Eynon N, Banting LK, Ruiz J, Cieszczyk P, Dyatlov DA, MaciejewskaKarlowska A, et al. ACTN3 R577X
polymorphism and teamsport performance: a study involving three European cohorts. J Sci Med Sport
.
201417:1026.
15
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
12. Gineviciene V, Jakaitiene A, Tubelis L, Kucinskas V. Variation in the ACE, PPARGC1A and PPARA
genesinLithuanianfootballplayers.EurJSportSci.
201214:17.
13. Juffer P, Furrer R, GonzálezFreire M, Santiago C, Verde Z, Serratosa L, et al. Genotype distributions in
toplevelsoccerplayers:aroleforACE
?IntJSportsMed.
200930:38792.
14. Ahmetov II, Williams A, Popov D, Lyubaeva E, Hakimullina A, Fedotovskaya O, et al. The combined
impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. Hum Genet
.
2009126(6):751–761.
15. Collins M, Xenophontos SL, Cariolou MA, Mokone GG, Hudson DE, Anastasiades L., et al. The ACE
gene and endurance performance during the South African Ironman Triathlons. Med Sci Sports Exerc.
200436:131420.
16. GómezGallego F, Santiago C, GonzálezFreire M, Muniesa CA, Fernández M, Pérez M, et al. Endurance
performance:genesorgenecombinations?IntJSporMed
.2009(30):6672.
17. Ma F, Yang Y, Li X, Zhou F, Gao C, Li M, et al. The association of sport performance with ACE and
ACTN3geneticpolymorphisms:asystematicreviewandmetaanalysis.PLoSONE
.20138:e54685.
18. Pimenta E, Coelho D, Cruz I. The ACTN3 genotype in soccer players in response to acute eccentric
training.EurJApplPhysiol
.2012112(4):14951503.
19. Hanson E, Ludlow A, Sheaff A, Park J, Roth S. ACTN3 genotype does not influence muscle power. Int J
SportsMed
.201031(11):834838.
20. McCauley T, Mastana S, Folland J. ACE I/D and ACTN3 R/X polymorphisms and muscle function and
muscularityofolderCaucasianmen.EurJApplPhysiol.
2010109(2):26977.
21. Bray MS, Hagberg JM, Perusse L, Rankinen T, Roth SM, Wolfarth B, et al. The Human Gene Map for
Performance and HealthRelated Fitness Phenotypes: The 20062007 Update. Med Sci Sports Exerc
.
200941(1):3472.
16
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
22. Rankinen T, Roth SM, Bray MS, Loos R, Pe´Russe L, Olfarth B, et al. Advances in exercise, fitness, and
performancegenomics.MedSciSportsExerc
.201042(5):835846.
23. Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, Easteal S, et al. ACTN3 genotype is associated
withhumaneliteathleticperformance.AmJHumGenet
.200373(3):627631.
24. Saunders CJ, September AV, Xenophontos SL, Cariolou MA, Anastassiades LC, Noakes TD, et al.
Association of the ACTN3 gene R577X polymorphism with endurance performance in Ironman triathlons. Ann
HumGene
.200771(6):777781.
25. MacArthur DG, North, KN. ACTN3: A genetic influence on muscle function and athletic performance.
ExercSportSciRev
.200735(1):3034.
26. Moran CN, Yang N, Bailey MES, Tsiokanos A, Jamurtas A, MacArthur DG, et al. Association analysis of
the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in
adolescentGreeks.EurJHumGene
.200615(1):8893.
27. Santiago C, GonzálezFreire M, Serratosa L, Morate FJ, Meyer T, GómezGallego F, et al. ACTN3
genotypeinprofessionalsoccerplayers.BrJSporMed
.200842(1):7173.
28. Vincent B, De Bock K, Ramaekers M, Eede E, Leemputte M, Hespel P, et al. ACTN3 (R577X) genotype is
associatedwithfibertypedistribution.PhysiolGeno
.200732(1):5863.
29. Walsh S, Liu D, Metter EJ, Ferrucci L, Roth SM. ACTN3 genotype is associated with muscle phenotypes
inwomenacrosstheadultagespan.JApplPhysiol
.2008105(5):14861491.
30.SvenssonMandDrustB.Testingsoccerplayers.JSportsSci
.200523(6):601618.
31. Chan S, Seto JT, MacArthur DG, Yang N, North KN, Head SI, et al. A gene for speed: contractile
properties of isolated whole EDL muscle from an actinin3 knockout mouse. Am J Physiol Cell Physiol
.
2008295(4):897904.
32. Chan S, Seto J, Houweling P, Yang N, North K, Head S. Properties of extensor digitorum longus muscle
andskinnedfibersfromadultandagedmaleandfemaleactn3knockoutmice.MusNer
.201143(1):3748.
17
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
33. Lucia A, GómezGallego F, Santiago C, Bandrés F, Earnest C, Rabadán M, et al. A gene for speed? The
evolutionandfunctionofalphaactinin3.Bioes
.200426(7):786795.
34.Klavora,P.Verticaljump:acriticalreview.StrCondJ
,Champaign.200022(5):7075.
35. Impellizzeri F, Rampinini E, Marcora S. Physiological assessment of aerobic training in soccer. J Sports Sci
23:583–592,2005.)
36. Miller AS, Dykes DD, Poleski HF. A simple salting out procedure for extracting DNA from human cells.
NuclAcidRes
.198816(3):1215.
37. Mills M, Yang N, Weinberger R, Vander Woude DL, Beggs AH, Easteal S, et al. Differential expression of
the actinbinding proteins, alphaactinin2 and3, in different species: implications for the evolution of
functionalredundancy.HumMolGenet
.200110(13):335346.
38. Sambrook J, Russel DW. Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor Laboratory,
NewYork.2001999.
39.WeirJP.QuantifyingtestretestreliabilityusingICCandtheSEM.JStren.CondRes.
200519(1):231240.
40. Niemi AK, Majamaa K. Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint
athletes.EurJHumGenet
.200513(8):965969.
41. Coelho DB, Mortimer LA, Condessa LA, Morandi RF, Oliveira BM, Marins JCB, et al. Intensity of real
competitive soccer matches and differences among player positions. Rev Bras Cineantropom Desemp Hum
.
201113(3):341347.
42. AlmeidaSilveira MI, Pérot C, Pousson M, Goubel F. Effects of stretchshortening cycle training on
mechanicalpropertiesandfibretypetransitionintheratsoleusmuscle.PflugersArch
.1994(34):289294.
43. Lamas L, Ugrinowitsch C, Campos G, Aoki M, Fonseca R, Regazzini M, et al. Treinamento de força
máxima x treinamento de potência: alterações no desempenho e adaptações morfológicas. Rev Bras Educ Fís
Esp
.200721(4):33140.
18
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
44. Clarkson PM, Devaney JM, GordishDressman H, Thompson PD, Hubal MJ, Urso M, et al. ACTN3
genotype is associated with increases in muscle strength in response to resistance training in women. J Appl
Physiol
.200599(1):154163.
45. Garganta J, Marques A, Maia J. Modelação tactica do jogo de futebol. Estudo da organizacão ofensiva em
equipasdealtorendimento.Ainvestigacãoemfutebol.EstudosIbéricos,
Porto.20025166.
TITLESOFTABLES
Table1.Samplecharacteristics.Dataforbodymass,maximumoxygenuptake,age,height,andbody
composition,fortheunder17(U17),under20(U20),andprofessionals(datapresentedasmean±standard
deviation).
Table2.RatingScaleofathletesaccordingtotheirresultsinphysicaltests.
Table 3. Comparison of ACTN3 genotypic frequency (RR, RX, XX) in soccer players classified according to
performance (1st, 2nd, 3rd, and 4th quartiles) in different physical tests. Values given as absolute (N) and
relativevalues(%).
Table 4. Comparison of ACTN3 allelic frequencies (R and X) in soccer players classified according to
performance (1st, 2nd, 3rd, and 4th quartiles) in different physical tests. Values given as absolute (N) and
relativevalues(%).
TITLESOFFIGURES
Figure 1: Polyacrylamide gel from the restriction site. Subjects with the 577R/R genotype present 2 fragments
of 205 and 86 bp 577R/X genotype, fragments of 205, 108, 97, and 86 bp and 577X/X genotype, fragments of
108,97,and86bp.Marker:50bpDNALadder
19
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
Table1.Samplecharacteristics.Dataforbodymass,maximumoxygenuptake,age,height,andbody
composition,fortheunder17(U17),under20(U20),andprofessionals(datapresentedasmean±
standarddeviation).
Category
N
O2ma
mLg1min1
Age
years
Bodymass
g
Height
cm
Bodyfat
U17(32)
56.1±2.0
17.30±5.33
73.30±6.79
181.33±7.04
9.15±1.89
U20(38)
57.2±2.9
20.60±3.66
73.36±7.90
180.61±8.20
9.21±2.08
Prof(68)
63.0±4.5
23.25±6.42
75.50±4.89
185.64±7.05
8.11±1.33
1
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
Table2.RatingScaleofathletesaccordingtotheirresultsinphysicaltests.
Classification
1
2
3
CM
S
O2ma
4ºQu.(Exc.)
6.0m/s
8.8m/s
7.6m/s
45cm
42cm
60mLkg1min1
3ºQu.(Good)
5.8m/s
8.5m/s
7.4m/s
39cm
37cm
55mLkg1min1
2ºQu.(Nor.)
5.5m/s
8.3m/s
7.2m/s
34cm
33cm
51mLkg1min1
1ºQu.(Weak)
5.5m/s
8.3m/s
7.2m/s
34cm
33cm
50mLkg1min1
Fourth quartile Weak (4ºQu. (Weak)) Third quartile Normal (3ºQu. (Norm.)) Second quartile Good (2ºQu.
(Good)) and First quartile Excellent (1ºQu. (Exc.)). Speed to the initial 10 m (V10), the remaining 20 m (V20)
and over the entire course 30 m (V30), Maximal oxygen uptake (VO2max), CounterMovement Jump (CMJ) and
SquatJump(SJ).
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies ( either sporadica lly or systematically, e ither printed or electronic) of the Article for any purpo se. It is not permitted to d istribute
the electronic copy of the articl e through online internet and/or intranet file sharing syste ms, electronic mailing or any other means whi ch may allow access to the Article. The use of al l or any
part of the Article for any Commercial Use is not permitted. The creation of deriva tive works from the Article is not permitted. The production of reprints fo r personal or commercial use is not
permitted. It is not permitted to remove, cover, o verlay, obscure, block, or change any copyrig ht notices or terms of use which the P ublisher may post on the Article. It is not permitted to
frame o r use framin g technique s to enclo se any trade mark, logo, or other pr oprietary in formation o f the Publi sher.
Table 3. Comparison of ACTN3 genotypic frequency (RR, RX, XX) in soccer players classified
according to performance (1st, 2nd, 3rd, and 4th quartiles) in different physical tests. Values given
asabsolute(N)andrelativevalues(%).
Quartileperformance
Gen.
4ºQu.Exc.,
N(%)
3ºQu.Good,
N(%)
2ºQu.Nor.
N(%)
1ºQu.Weak
N(%)
pvalue
1
RR
16(53)
14(47)
17(57)
9(30)
34
RX
13(43)
13(43)
10(33)
18(60)
XX
1(3)
3(10)
3(10)
3(10)
Total
30(100)
30(100)
30(100)
30(100)
2
RR
20(67)
14(47)
13(43)
9(30)
17
RX
8(27)
14(47)
15(50)
17(57)
XX
2(7)
2(7)
2(7)
4(13)
Total
30(100)
30(100)
30(100)
30(100)
3
RR
17(57)
17(57)
13(43)
9(30)
31
RX
11(37)
10(33)
15(50)
18(60)
XX
2(7)
3(10)
2(7)
3(10)
Total
30(100)
30(100)
30(100)
30(100)
O2ma
RR
13(42)
15(48)
12(40)
16(53)
4
RX
13(42)
14(45)
14(47)
14(47)
XX
5(16)
2(6)
4(13)
0(0)
Total
31(100)
31(100)
30(100)
30(100)
CM
RR
18(56)
17(53)
13(42)
11(35)
141
RX
11(34)
14(44)
17(55)
14(45)
XX
3(9)
1(3)
1(3)
6(19)
Total
32(100)
32(100)
31(100)
31(100)
S
RR
7(47)
7(47)
10(67)
4(29)
13
RX
7(47)
7(47)
5(33)
6(43)
XX
1(7)
1(7)
0(0)
4(29)
Total
15(100)
15(100)
15(100)
14(100)
Fourth quartile Weak (4ºQu. Weak) Third quartile Normal (3ºQu. Norm.) Second quartile Good (2ºQu. Good)
and First quartile Excellent (1ºQu. Exc.). Speed to the initial 10 m (V10), the remaining 20 m (V 20) and over the
entire 30 m (V30), Maximal oxygen uptake (VO2max), CounterMovement Jump (CMJ) and Squat Jump (SJ).
2testp≤0.05indicatessignificance.
1
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
Table 4. Comparison of ACTN3 allelic frequencies (R and X) in soccer players classified
according to performance (1st, 2nd, 3rd, and 4th quartiles) in different physical tests. Values given
asabsolute(N)andrelativevalues(%).
Quartileperformance
Allele
4ºQu.Exc.,
N(%)
3ºQu.Good,
N(%)
2ºQu.Nor.
N(%)
1ºQu.Weak
N(%)
pvalue
1
R
45(75)
41(68)
44(73)
36(60)
2
X
15(25)
19(32)
16(27)
24(40)
Total
60(100)
60(100)
60(100)
60(100)
2
R
48(80)
42(70)
41(68)
35(58)
4
X
12(20)
18(30)
19(32)
25(42)
Total
60(100)
60(100)
60(100)
60(100)
3
R
45(75)
44(73)
41(68)
36(60)
2
X
15(25)
16(27)
19(32)
24(40)
Total
60(100)
60(100)
60(100)
60(100)
O2ma
R
39(63)
44(71)
38(63)
46(77)
3
X
23(37)
18(29)
22(37)
14(23)
Total
62(100)
62(100)
60(100)
60(100)
CM
R
47(73)
48(75)
43(69)
36(58)
12
X
17(27)
16(25)
19(31)
26(42)
Total
64(100)
64(100)
62(100)
62(100)
S
R
21(70)
21(30)
25(83)
14(50)
5
X
9(30)
49(70)
5(17)
14(50)
Total
30(100)
70(100)
30(100)
28(100)
Fourth quartile Weak (4ºQu. Weak) Third quartile Normal (3ºQu. Norm.) Second quartile Good (2ºQu. Good)
and First quartile Excellent (1ºQu. Exc.). Speed to the initial 10 m (V10), the remaining 20 m (V 20) and over
the entire 30 m (V30), Maximal oxygen uptake (VO2max), CounterMovement Jump (CMJ) and Squat Jump (SJ).
2testp≤0.05indicatessignificance.
1
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies (eithe r sporadically or s ystematically, either print ed or electronic) of th e Article for an y purpose. It is not permitted to distribute
the electronic copy of the articl e through online internet and/or intranet file sharing systems, electronic mailing or any other means which may allow access to the Article. The use of all or any
part of the Article for any Commercial Use is not permitted. The cr eation of derivativ e works from the Article is not permitted. The production of reprints for personal or commercial use is not
permitted. It is not permitted to remove, cover, overl ay, obscure, block, or change any copyright no tices or te rms of use which the Publisher may post on the Article. It is not p ermitted to
frame o r use framin g techniques to enclose any tradem ark, logo, or other pr oprietary in formation o f the Publis her.
COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA
This document is protected by international copyright laws. No additional reproduction is authorized. It is permitted for personal use to download and save only one file and print only one
copy of th is Article. It is not permitted to make additional copies ( either sporadica lly or systematically, e ither printed or electronic) of the Article for any purpo se. It is not permitted to d istribute
the electronic copy of the articl e through online internet and/or intranet file sharing syste ms, electronic mailing or any other means whi ch may allow access to the Article. The use of al l or any
part of the Article for any Commercial Use is not permitted. The creation of deriva tive works from the Article is not permitted. The production of reprints fo r personal or commercial use is not
permitted. It is not permitted to remove, cover, o verlay, obscure, block, or change any copyrig ht notices or terms of use which the P ublisher may post on the Article. It is not permitted to
frame o r use framin g technique s to enclo se any trade mark, logo, or other pr oprietary in formation o f the Publi sher.